Results 281 to 290 of about 100,641 (375)

Acute Pharmacodynamic Effects of Oral Levodopa on Blood Pressure in Parkinson's Disease. [PDF]

open access: yesPharmacotherapy
Longardner K   +7 more
europepmc   +1 more source

Local field potentials and motor performances modulation in response to stimulation and levodopa: a prospective study on Parkinson’s Disease patients on chronic Deep Brain Stimulation

open access: gold
Alfredo Conti   +7 more
openalex   +1 more source

rs6971 TSPO polymorphism in Parkinson's disease

open access: yes
Movement Disorders, EarlyView.
Bina Patel   +9 more
wiley   +1 more source

Monoaminergic Networks of Cognitive and Behavioral Symptoms in Early Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Parkinson's disease (PD) is associated with several behavioral and cognitive symptoms, the neurobiological background of which is not yet fully understood. Objectives The aim was to investigate the association between monoamine function and four specific nonmotor symptoms in early PD using the Parkinson's Progression Markers ...
Kalle J. Niemi   +3 more
wiley   +1 more source

Advertising to Healthcare Professionals: Insights from Parkinson's Disease in the Movement Disorders Journal

open access: yes
Movement Disorders, EarlyView.
Augusto Rachão   +12 more
wiley   +1 more source

Plasma Glucosylsphingosine in GBA1 E365K, N409S, and L483P Heterozygous Mutation Carriers

open access: yesMovement Disorders, EarlyView.
Abstract Background GBA1 encodes the lysosomal enzyme glucocerebrosidase, with key substrates that include glucosylceramide and glucosylsphingosine. The E365K variant is the most common variant in GBA1 that is associated with Parkinson's disease (PD) but is not associated with Gaucher disease.
Julian Agin‐Liebes   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy